Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 20,754 |
|
|||||
| News | - | ||||||
| Day High | 4.4999 | Low High |
|||||
| Day Low | 4.28 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0418 | -0.96% | 4.3082 | 16:13:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.455 | 4.28 | 4.4999 | 4.3082 | 4.35 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 274 | 20,754 | $ 4.42 | $ 91,649 | - | 4.28 - 15.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:04 | 2 | $ 4.45 | USD |
Moleculin Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 144.01M | 33.41M | - | 0 | -29.77M | -0.89 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.49 | 5.00 | 4.28 | 4.49 | 18,353 | -0.1818 | -4.05% |
| 1 Month | 5.58 | 6.2348 | 4.28 | 5.10 | 27,681 | -1.27 | -22.79% |
| 3 Months | 7.575 | 10.35 | 4.28 | 7.17 | 114,712 | -3.27 | -43.13% |
| 6 Months | 7.575 | 15.75 | 4.28 | 8.61 | 149,801 | -3.27 | -43.13% |
| 1 Year | 11.25 | 15.75 | 4.28 | 8.87 | 153,671 | -6.94 | -61.70% |
| 3 Years | 52.2345 | 59.85 | 4.28 | 24.66 | 162,455 | -47.93 | -91.75% |
| 5 Years | 23.10 | 131.70 | 4.28 | 26.67 | 974,041 | -18.79 | -81.35% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. |
